1. Yuan R, Yan Y, Deng L, Li F, et al.
   Risk factors of metabolic dysfunction-associated fatty liver disease in people living with HIV receiving antiretroviral therapy.
   AIDS 2025.
   


2. Wang H, Fan H, Guo C, Zhang X, et al.
   Exploring Potential Associations Between HIV Acquisition and Biological Aging: Insights from a Bidirectional Mendelian Randomization Study.
   AIDS Res Hum Retroviruses 2025.
   


3. Person AK, Kelley CF.
   World AIDS Day-At a Crossroads.
   JAMA 2025.
   


4. Tu SS, Bonis T, Sinha MS, Slade DH, et al.
   Combination-Only Approvals as a Barrier to Affordable HIV Care.
   JAMA 2025.
   


5. Tien D, Chandiwana N, Shazi G, Chen G, et al.
   Dolutegravir-based therapy, diet, physical activity and weight gain: a 48-week prospective cohort in South Africa.
   J Acquir Immune Defic Syndr 2025.
   


6. D'Angelo AB, Patel VV, Carrico AW, Grov C, et al.
   To err is human, to persist is diabolical: Are we repeating the same cost and insurance coverage mistakes again with injectable PrEP?
   J Acquir Immune Defic Syndr 2025.
   


7. Raskopf W, Mbewe E, Adams H, Buda A, et al.
   a. Nutritional Status and Cognitive Function in Children with or exposed to HIV: Evidence from the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study.
   J Acquir Immune Defic Syndr 2025.
   


8. Mpofu R, Chandiwana N, Sokhela S, Moorhouse M, et al.
   The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in Participants with HIV-associated Tuberculosis.
   J Acquir Immune Defic Syndr 2025.
   


9. Makarova N, Singletary T, Peet MM, Kelley K, et al.
   Partial post-exposure protection by topical inserts containing tenofovir alafenamide fumarate/elvitegravir in a macaque model of rectal SHIV infection.
   J Infect Dis 2025.
   


10. Bunjun R, Lurie M, Dabee S, Barnabas S, et al.
    Chlamydia trachomatis-specific T Cell Immunity Reflects Widespread Exposure in South African Adolescents and Young Women.
    J Infect Dis 2025.
    


11. Tewari SE, Hoffman R, Lockman S, Flanagan CF, et al.
    Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness.
    J Infect Dis 2025.
    


12. Afsari B, Ramaswami R, Lurain K, Tagawa T, et al.
    Spatial Transcriptomics of Patients With Kaposi Sarcoma Identifies Mechanisms of Immune Evasion.
    J Med Virol 2025;97:e70728.
    


13. Karmochkine M, Mariaggi AA, Leducq V, L'Honneur AS, et al.
    KSHV Acquired During Chemsex With Resultant Multicentric Castleman's Disease in a Patient Successfully Treated for HIV.
    J Med Virol 2025;97:e70749.
    


14. Deng Z, Zhang X, Zhu A, Yang X, et al.
    Subset Remodeling of MAIT and NK Cells Correlates With Immune Reconstitution in People Living With HIV Following Four Years of Antiretroviral Therapy.
    J Med Virol 2025;97:e70732.
    


15. Yang T, Chen M, Zhou M, Deng X, et al.
    The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation.
    J Virol 2025.
    


16. Wang Y, Fu S, Wang X, Gao G, et al.
    Phosphorylation of Shiftless by casein kinase 1 delta/epsilon is required for its antiviral activity.
    J Virol 2025.
    


17. Baldino AM, Mumby MJ, Edgar CR, Olabode AS, et al.
    Ancestral reconstruction supports that loss of Nef-mediated T cell modulation coincided with the emergence of pathogenic lentiviruses.
    J Virol 2025.
    


18. Thornton J.
    Fiji faces major HIV outbreak.
    Lancet 2025.
    


19. Ratevosian J, Beyrer C, Chola M, Huchko M, et al.
    The New U.S. Global Health Strategy - A Reset of America's Health Cooperation.
    N Engl J Med 2025;393:2180-2182.
    


20. Maduranga S, Valencia BM, Sigera C, Weeratunga P, et al.
    Between- and within-host mutation of dengue virus.
    Virology 2025;615:110750.
    


21. Wise J.
    HIV action plan: At-home tests to be trialled through the NHS app.
    BMJ 2025;391:r2530.
    

Display articles in

• Abstract format